The clinician may consider disopyramide, procainamide, or quinidine on an individual basis.

临床医师基于个体化考虑选用双异丙吡、普鲁卡因或。

Disopyramide, procainamide, and quinidine are considered third-line agents in this situation.

这些情况下，双异丙吡、普鲁卡因和作为三线药物。